Early Use of Rituximab in New-Onset Generalized Myasthenia Gravis: RINOMAX Trial
Two papers, an original article and follow up data from a randomized clinical trial on the use of rituximab for new-onset generalized Myasthenia Gravis (MG) has been reviewed. The studies assess the e...
16 Nov 202510min
CAR-T cell therapy, neurological risks and potential use
The episode combines two papers discussing both the potentiyal use of CAR T cells therapy in various autoimmune neurological diseases like Multiple Sclerosis and Myasthenia Gravis, along with potentia...
9 Nov 202512min
Active Inference Model of Functional Neurological Disorder
This article outlines the Active Inference Model, which is one of the proposed pathophysiological mechanisms of functional neurological disorder (FND).
2 Nov 202555min
Are COVID-19, RSV, and Influenza vaccines safe and effective?
This study presents a systematic review and meta-analysis of the effectiveness and safety of immunizations against three major respiratory viruses: Covid-19, respiratory syncytial virus (RSV), and inf...
2 Nov 202533min
Outcome Measures for Adult Becker Muscular Dystrophy Progression
This article is an excerpt from a natural history study published in Neurology in 2025, focusing on the sensitivity of clinical outcome measures in assessing adult patients with Becker Muscular Dystro...
20 Okt 202513min
2025 ILAE 2025 updated seizure classification
This journal article provides a practical guide to understanding and applying the International League Against Epilepsy (ILAE) updated seizure classification of 2025. It explains how the new system, w...
19 Okt 202513min
Myasthenia Gravis 2025 Updated Management Guidelines from the Association of British Neurologists
The paper provides updated 2025 management guidelines from the Association of British Neurologists (ABN) for autoimmune myasthenia gravis (MG). The document outlines several key updates from previous ...
15 Okt 202533min
Iatrogenic Cerebral Amyloid Angiopathy (CAA) and CAA related inflammation (CAA-ri)
The papers summarized focus on Cerebral Amyloid Angiopathy (CAA), particularly the emerging clinical phenomenon of iatrogenic CAA (iCAA). iCAA is hypothesized to occur following the transmission of Am...
15 Okt 202525min
